Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Los Angeles
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Los Angeles, CA

Studies commonly pay $75 to $4,500 per completed study

2,951 clinical trials are currently recruiting participants within 30 miles of Los Angeles. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,951studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Los Angeles right now

Top 25 of 2,951 recruiting studies, sorted by proximity — each links to its official registry page

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (10.3 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) — Los Angeles, California (10.3 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma Phase 1 Interventional 46 participants sought
University of Southern California — Los Angeles, California (10.3 mi) · Sponsor: SciTech Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04234048)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (10.3 mi) · Sponsor: Pacific Edge Limited
See eligibility & contact on ClinicalTrials.gov (NCT06394869)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) — Burbank, California (7.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (2.8 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Multiple Myeloma Phase 1 Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (24.6 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07409246)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retina-Vitreous Associates Medical Group — Beverly Hills, California (2.8 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Low-Risk, Early Stage Breast Cancer N/A Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (8.9 mi) · Sponsor: IceCure Medical Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07629206)

Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)

Actinic Keratosis (AK) N/A Observational 30 participants sought
Ablon Skin Institute and Research Center — Manhattan Beach, California (15.8 mi) · Sponsor: Avant Health LLC
See eligibility & contact on ClinicalTrials.gov (NCT07657988)

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Phase 1, Phase 2 Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (24.6 mi) · Sponsor: City of Hope Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT03011814)

Regional Blocks for Lateral Condyle Fractures

Fractures, Closed, Humeral Fractures Phase 4 Interventional 90 participants sought
Orthopaedic Institute for Children — Los Angeles, California (10.3 mi) · Sponsor: University of California, Los Angeles
See eligibility & contact on ClinicalTrials.gov (NCT03796572)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (15.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Age-Related Macular Degeneration, Geographic Atrophy N/A Interventional 125 participants sought
Eye Physicians of Long Beach — Long Beach, California (27.0 mi) · Sponsor: VisionCare, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05438732)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (10.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Spinal Cord Injury, Pressure Injury N/A Interventional 808 participants sought
VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California (27.0 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT06529094)

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease Phase 1, Phase 2 Interventional 54 participants sought
UCLA TMS Clinical and Research Service — Los Angeles, California (10.3 mi) · Sponsor: University of California, Los Angeles
See eligibility & contact on ClinicalTrials.gov (NCT06597942)

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Migraine Phase 2 Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (10.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06602479)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Disney Family Cancer Center — Burbank, California (7.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants

Movement Disorders, Neurorehabilitation N/A Interventional 50 participants sought
UCLA Neural Engineering and Computation Lab — Los Angeles, California (10.3 mi) · Sponsor: University of California, Los Angeles
See eligibility & contact on ClinicalTrials.gov (NCT07236892)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
California Research Institute — Los Angeles, California (10.3 mi) · Sponsor: OncoNano Medicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06022029)

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

Advanced Cancer, Solid Tumor Phase 1 Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (24.6 mi) · Sponsor: Proviva Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06190886)
Actively enrolling

Studies you may be able to join near Los Angeles

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Los Angeles

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Bayview Research Group

★ 4.7
12626 Riverside Dr #404, Valley Village, CA 91607
(800) 831-8308
"Beautiful ❤️ office friendly staff"
— Rebecca Buehler, 5★

Mills Clinical Research

8280 Santa Monica Blvd, West Hollywood, CA 90046
(310) 550-2271

Schuster Medical Research

★ 5.0
5000 Van Nuys Blvd #210, Sherman Oaks, CA 91403
(818) 788-0747
"Patient, they really listened and were very clear every step of the way. They wanted to make sure I understood. I really feel like they care about me…"
— ryan kemp, 5★

La Clinical Trials

★ 5.0
847 N Hollywood Way, Burbank, CA 91505
(818) 526-7645
"Eli is the bomb , never get stuck twice . He’s always on point . Thanks Eli and everybody working there ."
— Kevin Juengain, 5★

UCLA General Clinical Research

★ 5.0
10833 Le Conte Ave, Los Angeles, CA 90095
(310) 825-5225

David Berz, MD, PhD, MPH - Valkyrie Clinical Trials INC

★ 4.5
2080 Century Pk E Ste 803, Los Angeles, CA 90067
(424) 535-1874
"Tengo dos meses en tratamiento con el Dr Berz, mi oncóloga anterior, me mandó con él, porque ella ya no tenía más por hacer conmigo, así que me refir…"
— Martha P. Aussenac Gonzalez, 5★

Unison Clinical Trials

★ 5.0
4955 Van Nuys Blvd #201, Sherman Oaks, CA 91403
(818) 981-1555
"I had an excellent experience with Unison Clinical Trials. The staff was incredibly friendly, professional, and attentive throughout my visits. Jess,…"
— Anthony M, 5★

UCLA Clinical and Translational Research Center

Center of Health Sciences, 10833 Le Conte Ave BE-144, Los Angeles, CA 90095
(310) 825-5225

ONCOtherapeutics, CRO

9201 Sunset Blvd Suite 317, West Hollywood, CA 90069
(310) 623-1200

Clinical trials in Los Angeles: what's recruiting

The Los Angeles area currently has 2,951 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Los Angeles, the most active research areas are:

  • Cancer & Oncology11 studies
  • Brain & Mental Health2 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Los Angeles, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Los Angeles

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Los Angeles participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Los Angeles safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Los Angeles, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Los Angeles?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Los Angeles.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Los Angeles typically complete one or two studies per year.

Paid clinical trials near Los Angeles

Other metros within reach

Glendale, CA2,974 Torrance, CA3,259 Santa Clarita, CA2,378 Long Beach, CA3,380 Thousand Oaks, CA662 Fullerton, CA3,270 Garden Grove, CA3,204 Palmdale, CA127

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Los Angeles Chronic Kidney Disease (HealthMatch) in Los Angeles Bladder Issues Due To Spinal Cord Injury in Los Angeles All conditions

More of CA

Long Beach3,380 Fullerton3,270 Torrance3,259 Anaheim3,214 Garden Grove3,204 Pomona3,172 Glendale2,974 Huntington Beach2,879 Santa Clarita2,378 Hayward2,267 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts